Australia markets closed

Flora Growth Corp. (FLGC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.84+0.84 (+12.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.00
Open6.76
Bid0.00 x 800
Ask0.00 x 1000
Day's range6.76 - 7.85
52-week range2.85 - 10.23
Volume3,859,162
Avg. volume1,930,219
Market cap329.467M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.47
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.00
  • Flora Growth Executes International Sales Agreement to Enter Australian Medical Cannabis and Over-The-Counter CBD Market
    Business Wire

    Flora Growth Executes International Sales Agreement to Enter Australian Medical Cannabis and Over-The-Counter CBD Market

    MIAMI, Fla., July 29, 2021--Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has entered into a non-binding Letter of Intent ("LOI") with Evergreen Pharmacare Pty Ltd. ("Evergreen"), a licensed Australian importer and distributor of medical cannabis products, to supply its premium dried flower and derivative products. The Company expects to ship its medical-grade

  • Why Shares of Flora Growth Are Soaring Today
    Motley Fool

    Why Shares of Flora Growth Are Soaring Today

    Flora Growth (NASDAQ: FLGC) surged as high as $7.95 in afternoon trading Wednesday, a rise of more than 50% to the highest level the stock has touched since its initial public offering in May. Colombia-based Flora, which just announced plans to move its corporate headquarters to Miami from Canada, cultivates cannabis and processes it into medicinal-grade cannabis oil and other products, which it supplies to pharmacies, cosmetics companies, and medical clinics. The cream, already sold in Canada, will now also be sold through Flora's distribution channels in Latin America.

  • Flora Growth to Partner with Avaria to Distribute Award-Winning Pain Cream Brand KaLaya Across LATAM & Produce Its CBD Formulations
    Business Wire

    Flora Growth to Partner with Avaria to Distribute Award-Winning Pain Cream Brand KaLaya Across LATAM & Produce Its CBD Formulations

    MIAMI, July 27, 2021--Flora Growth Corp. (NASDAQ: FLGC) ("Flora", "Flora Growth", or the "Company"), an all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce it has signed a non-binding Letter of Intent ("LOI") to form a joint venture ("the JV") with Canadian based Avaria Inc ("Avaria"), the manufacturer and owner of KaLaya – an award-winning pain cream distributed nation-wide across Canada.